Original Research

Schisandrin B protects against angiotensin II-induced endotheliocyte deficits by targeting Keap1 and activating Nrf2 pathway

Han J, Shi X, Zheng Z, Zhang B, Shi F, Jiang L, Xu J

Drug Design, Development and Therapy 2018, 12:3985-3997

Published Date: 22 November 2018